HR 6038 · 102th Congress · Commerce

To amend title 35, United States Code, to permit separate patent extensions for each product under a patent which is subject to full regulatory review and approval.

Introduced 1992-09-25· Sponsored by Rep. Levine, Mel [D-CA-27]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Intellectual Property and Judicial Administration.(1992-09-28)

Plain Language Summary

[AI summary unavailable — showing source text] Amends Federal patent law to permit separate patent extensions for certain drug products: (1) under a patent which is subject to full regulatory review and approval; and (2) which were developed at a qualified nonprofit institution of higher education.…

Summarized by Claude AI · Non-partisan · For informational purposes only